Ambrx
Brad Stiles has a strong background in process and media development in the biotech industry. Brad started their career at American Cyanamid/BASF in 1992 as a Manager/Principal Scientist. Brad then moved to Life Technologies (GIBCO) in 2002, where they served as a Manager/Principal Scientist leading media product development teams. Brad joined XOMA in 2006 as a Manager in the Process Development Sciences Dept., responsible for media and process development and leading a team. Brad later joined Agenus in 2016, where they held roles as a Senior Manager in Upstream Development and Process Development. Currently, they are working at Ambrx as a Principal Scientist.
Brad Stiles received their Ph.D in Insect Virology from Purdue University, from 1975 to 1980.
This person is not in any offices
Ambrx
Ambrx, Inc. is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics. Ambrx is based on a fundamental advance in protein biosynthesis that enables the company to genetically engineer proteins with new amino acid building blocks beyond the common twenty, enabling the biosynthesis of proteins with new physical, chemical and pharmacological properties.